Erick Lucera
Finanzdirektor/CFO bei EDITAS MEDICINE, INC.
Vermögen: 614 949 $ am 30.04.2024
Profil
Erick J.
Lucera is currently serving as an Independent Director at Beyond Air, Inc. and as a Director at Beyond Air Ltd.
He is also an Independent Director at SAB Biotherapeutics, Inc. and holds the position of Chief Financial Officer & Executive Vice President at Editas Medicine, Inc. In his former roles, Mr. Lucera served as the Chief Executive Officer at Triathlon Fund Management LLC from 2004 to 2007.
He was also a Director at Bone Biologics Corp.
from 2021 to 2024 and a Vice President at Eaton Vance Management from 2008 to 2012.
Additionally, he worked as a Principal at Independence Investments LLC from 1995 to 2004 and as the Vice President-Corporate Development at Nuwellis, Inc. in 2012.
Mr. Lucera also served as a Portfolio Manager at Triathlon Life Sciences Fund LP and as the Vice President-Corporate Development at Aratana Therapeutics, Inc. from 2012 to 2015.
He held the position of Chief Financial Officer, Secretary & Treasurer at Valeritas Holdings, Inc. from 2016 to 2019 and was a Principal at Pricewaterhouse & Co. from 1990 to 1993.
Additionally, he served as the Chief Financial Officer at AVEO Pharmaceuticals, Inc. from 2020 to 2023 and as the Chief Financial Officer, Secretary & Treasurer at Viventia Bio, Inc. in 2015.
Mr. Lucera completed his graduate degree from Boston College in 1999.
He also holds an MBA from Indiana University, which he obtained in 1995.
Furthermore, he received his undergraduate degree from the University of Delaware in 1990.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EDITAS MEDICINE, INC.
0,14% | 20.05.2024 | 116 829 ( 0,14% ) | 609 847 $ | 30.04.2024 |
BEYOND AIR, INC.
0,01% | 20.03.2024 | 4 342 ( 0,01% ) | 5 102 $ | 30.04.2024 |
| 13.05.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Erick Lucera
| Unternehmen | Position | Beginn |
|---|---|---|
| BEYOND AIR, INC. | Direktor/Vorstandsmitglied | 10.08.2017 |
| SAB BIOTHERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 03.04.2023 |
| EDITAS MEDICINE, INC. | Finanzdirektor/CFO | 17.05.2023 |
Beyond Air Ltd.
 Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Direktor/Vorstandsmitglied | 01.08.2017 |
Ehemalige bekannte Positionen von Erick Lucera
| Unternehmen | Position | Ende |
|---|---|---|
| BONE BIOLOGICS CORPORATION | Direktor/Vorstandsmitglied | 11.01.2024 |
| AVEO PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.02.2023 |
| VALERITAS HOLDINGS, INC. | Finanzdirektor/CFO | 01.12.2019 |
Viventia Bio, Inc.
 Viventia Bio, Inc. BiotechnologyHealth Technology Viventia Bio, Inc. operates as a biologics oncology company, which focuses on designing, engineering, and developing targeted protein therapeutics. The company was founded by Leslie Lewis Dan in October 2012 and is headquartered in Winnipeg, Canada. | Finanzdirektor/CFO | 01.08.2016 |
| ARATANA THERAPEUTICS INC | Corporate Officer/Principal | 01.04.2015 |
Ausbildung von Erick Lucera
| University of Delaware | Undergraduate Degree |
| Indiana University | Masters Business Admin |
| Boston College | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| NUWELLIS, INC. | Health Technology |
| BEYOND AIR, INC. | Health Technology |
| BONE BIOLOGICS CORPORATION | Health Technology |
| SAB BIOTHERAPEUTICS, INC. | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Triathlon Fund Management LLC
 Triathlon Fund Management LLC Investment ManagersFinance Triathlon Fund Management LLC is a hedge fund headquartered in Boston. | Finance |
Triathlon Life Sciences Fund LP
 Triathlon Life Sciences Fund LP Investment ManagersFinance Part of Triathlon Fund Management LLC, Triathlon Life Sciences Fund LP is a private equity fund. | Finance |
| Pricewaterhouse & Co. | Commercial Services |
Eaton Vance Management
 Eaton Vance Management Investment ManagersFinance Eaton Vance Management (EVM) is a registered mutual fund manager headquartered in Boston, Massachusetts. The firm was founded in 1979 when Eaton & Howard merged with Vance, Sanders & Co. Prior to March 2021, they were a wholly-owned subsidiary of Eaton Vance Corp. Their direct owner is Morgan Stanley Domestic Holdings, Inc., ultimately held by Morgan Stanley (NYSE: MS). EVM provides investment advice to institutional clients, mutual funds, other pooled investment vehicles, and retail separately managed accounts. | Finance |
Aratana Therapeutics, Inc.
 Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS. | Health Technology |
Independence Investments LLC
 Independence Investments LLC Investment ManagersFinance Founded in 1982, Independence Investment LLC is a wholly owned investment management subsidiary of John Hancock Financial Services, Inc. (NYSE: JHF) The firm is located in Boston. | Finance |
Valeritas Holdings, Inc.
 Valeritas Holdings, Inc. Medical SpecialtiesHealth Technology Valeritas Holdings, Inc. develops and commercializes insulin delivery devices. The company was founded by Leisa Swanson and Robert R. Gonnelli on August 2, 2006 and is headquartered in Bridgewater, NJ. | Health Technology |
Viventia Bio, Inc.
Viventia Bio, Inc. BiotechnologyHealth Technology Viventia Bio, Inc. operates as a biologics oncology company, which focuses on designing, engineering, and developing targeted protein therapeutics. The company was founded by Leslie Lewis Dan in October 2012 and is headquartered in Winnipeg, Canada. | Health Technology |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Health Technology |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |